Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Impact of Social Determinants of Health on Overall Survival in Patients with AML By European Leukemianet Risk Group

Shai O. Shimony, Yating Wang, Angel Cronin, Thomas P Walsh, Anne Charles, Natalie Slopen, Maximilian Stahl, Rebecca P. Bystrom, Marlise R. Luskin, Gregory Abel, Daniel J. DeAngelo, Richard M Stone, R. Coleman Lindsley, Andrew Hantel

Blood (2024) 144 (Supplement 1): 5171.

https://doi.org/10.1182/blood-2024-203644

Published: 2024

Journal Articles

Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer

Lauren E. Merz, Yating Wang, Elad Sharon, Thomas P Walsh, Gregory Abel, Andrew Hantel

Blood (2024) 144 (Supplement 1): 5073.

https://doi.org/10.1182/blood-2024-201828

Published: 2024

Journal Articles

A National Survey of Oncologists' Perspectives on the Ethical Implications of Artificial Intelligence in Cancer Care

Andrew Hantel, Jonathan M. Marron, Kenneth Kehl, Richard Sharp, Thomas P Walsh, Eliezer Van Allen, Gregory A Abel

Blood (2023) 142 (Supplement 1): 2347.

https://doi.org/10.1182/blood-2023-175030

Published: 2023

Journal Articles

Alignment of Later Phase Clinical Trial Eligibility Criteria with Drug Safety in Acute Leukemia: Minimizing Unnecessary Patient Risk and Exclusion

Elizabeth Warner, Thomas P Walsh, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A Abel, Andrew Hantel

Blood (2023) 142 (Supplement 1): 263.

https://doi.org/10.1182/blood-2023-174880

Published: 2023

Journal Articles

Development of a Real-Time Dashboard Characterizing Acute Leukemia Clinical Trial Enrollment Diversity at the Practice, Investigator, and Individual Clinician Level

Andrew Hantel, Kelsey Y Li, Saima Awan, Thomas P Walsh, Emerald D Littlejohn, Daniel J. DeAngelo, Christopher S. Lathan, Gregory A Abel

Blood (2023) 142 (Supplement 1): 132.

https://doi.org/10.1182/blood-2023-174899

Published: 2023

NARROW

Impact of Social Determinants of Health on Overall Survival in Patients with AML By European Leukemianet Risk Group

Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer

A National Survey of Oncologists' Perspectives on the Ethical Implications of Artificial Intelligence in Cancer Care

Alignment of Later Phase Clinical Trial Eligibility Criteria with Drug Safety in Acute Leukemia: Minimizing Unnecessary Patient Risk and Exclusion

Development of a Real-Time Dashboard Characterizing Acute Leukemia Clinical Trial Enrollment Diversity at the Practice, Investigator, and Individual Clinician Level

Email alerts

ASH Publications

American Society of Hematology

Impact of Social Determinants of Health on Overall Survival in Patients with AML By European Leukemianet Risk Group

Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer

A National Survey of Oncologists' Perspectives on the Ethical Implications of Artificial Intelligence in Cancer Care

Alignment of Later Phase Clinical Trial Eligibility Criteria with Drug Safety in Acute Leukemia: Minimizing Unnecessary Patient Risk and Exclusion

Development of a Real-Time Dashboard Characterizing Acute Leukemia Clinical Trial Enrollment Diversity at the Practice, Investigator, and Individual Clinician Level

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only